Diasorin | DIA - Selling And Administration Expenses

Stock Price
63.42
Daily Change
-0.58 -0.91%
Monthly
-5.26%
Yearly
-33.35%
Q1 Forecast
62.02

Diasorin reported EUR100.15M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Avanos Medical USD 78.8M 1.2M Dec/2025
Brookdale Senior Living USD 4.16B 4.06B Sep/2025
Cencora USD 1.75B 75.99M Sep/2025
Diasorin EUR 100.15M 18.26M Sep/2025
Encompass Health USD 68.4M 12.3M Dec/2025
Enovis USD 270.44M 6.82M Dec/2025
GE HealthCare Technologies USD 966M 63M Sep/2025
OPKO Health USD 53.8M 5.8M Sep/2025
Pediatrix Medical Group USD 412.55M 10.46M Dec/2024
Veradigm USD 32.52M 27.13M Sep/2022
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025